Hemab Therapeutics raises $135m for prophylactic treatments for bleeding and thrombotic disorders

Hemab Therapeutics raises $135m for prophylactic treatments for bleeding and thrombotic disorders

Hemab Therapeutics, a clinical-stage biotechnology company, has raised $135 million in a Series B financing round for advancing prophylactic treatments for underserved bleeding and thrombotic disorders. The company anticipates using the proceeds from the round to complete an ongoing phase 1/2 study of its bispecific antibody HMB-001 in Glanzmann Thrombasthenia apart from advancing its upcoming […]

Pyxis Oncology raises $152m in Series B round for cancer therapies

Pyxis Oncology raises $152m in Series B round for cancer therapies

Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company is developing antibody-drug conjugates (ADCs), immunotherapies, and other biologics for the treatment of difficult-to-treat cancers. Pyxis Oncology’s Series B round also saw the participation of additional new investors – Perceptive […]

US medical device company Adagio Medical raises $42.5m in Series E

US medical device company Adagio Medical raises $42.5m in Series E

Adagio Medical, a California-based medical device company focused on developing treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), has raised $42.5 million in a Series E equity financing round. The company has also developed the intelligent Continuous Lesion Ablation System (iCLAS). Its Series E financing round included new investors ArrowMark Partners, Perceptive Advisors, and […]